Philipp B. Staber

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

Barbara Eichhorst, Carsten Utoft Niemann, Arnon P. Kater et al. · New England Journal of Medicine · 2023 · 268 citations · Full text

DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling

Olga A. Guryanova, Kaitlyn Shank, Barbara Spitzer et al. · Nature Medicine · 2016 · 243 citations · Full text

Hematological Malignancy, Chromatin, Mixed-phenotype Acute Leukemia +10

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

Christoph Kornauth, Tea Pemovska, Gregory I. Vladimer et al. · Cancer Discovery · 2021 · 196 citations · Full text

Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study

Berend Snijder, Gregory I. Vladimer, Nikolaus Krall et al. · The Lancet Haematology · 2017 · 180 citations · Full text

Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)

Emmanuel Bachy, Vincent Camus, Catherine Thiéblemont et al. · Journal of Clinical Oncology · 2021 · 179 citations · Full text